M M Wagner

672 total citations
36 papers, 508 citations indexed

About

M M Wagner is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, M M Wagner has authored 36 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in M M Wagner's work include Occupational and environmental lung diseases (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Air Quality and Health Impacts (5 papers). M M Wagner is often cited by papers focused on Occupational and environmental lung diseases (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Air Quality and Health Impacts (5 papers). M M Wagner collaborates with scholars based in United Kingdom, United States and Switzerland. M M Wagner's co-authors include J. C. Wagner, Richard Edwards, Donald C. Paul, Daniel C. Williams, C. Darke, Mark J. Campbell, Mary Ann Jordan, Chuan Shih, Richard C. Winneker and Leslie Wilson and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Endocrinology.

In The Last Decade

M M Wagner

36 papers receiving 457 citations

Peers

M M Wagner

PRM

ONCOL

PHEOH

W. David McGuinn United States

Virginia K. Pierce United States

Gerald Sufrin United States

Hyunju Park South Korea

Sarah Lowndes United Kingdom

Barrett Jc United States

Shoichi Inoue Japan

S. Matthews United States

A Dubreuil France

W. David McGuinn United States

M M Wagner

298 ×1.5

PRM

254 ×1.9

349 ×3.8

ONCOL

74 ×1.1

PHEOH

66 ×1.1

Citations per year, relative to M M Wagner M M Wagner (= 1×) peers W. David McGuinn

Countries citing papers authored by M M Wagner

Since Specialization

Citations

This map shows the geographic impact of M M Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M M Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M M Wagner more than expected).

Fields of papers citing papers by M M Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M M Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M M Wagner. The network helps show where M M Wagner may publish in the future.

Co-authorship network of co-authors of M M Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of M M Wagner. A scholar is included among the top collaborators of M M Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M M Wagner. M M Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gordon, Michael S., Robert Ilaria, Dinesh P. de Alwis, et al.. (2012). A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71(1). 21–27. 13 indexed citations

Simon, George R., Robert Ilaria, Mika A. Sovak, et al.. (2011). A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors. Cancer Chemotherapy and Pharmacology. 68(5). 1233–1241. 17 indexed citations

Ilaria, Robert, George R. Simon, Mika A. Sovak, et al.. (2007). Phase I study of LY573636-sodium, an acylsulfonamide anti-cancer compound with a novel mechanism of action, administered as 2-hour IV infusion in patients with advanced solid tumors. Journal of Clinical Oncology. 25(18_suppl). 2515–2515. 7 indexed citations

Norman, Bryan H., Joseph M. Gruber, Sean P. Hollinshead, et al.. (2002). Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1). Bioorganic & Medicinal Chemistry Letters. 12(6). 883–886. 55 indexed citations

Wagner, M M, Donald C. Paul, Chuan Shih, et al.. (1999). In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines. Cancer Chemotherapy and Pharmacology. 43(2). 115–125. 68 indexed citations

Tando, Yusuke, et al.. (1999). メッセンジャーとしてCa 2+ とプロテインキナーゼCの両方を必要とするセルレイン誘発性NF-κB/Rel活性化. American Journal of Physiology-Legacy Content. 277. 678–686. 2 indexed citations

Neil, S. Mac, M M Wagner, Sarah E. Hill, et al.. (1992). Signal transduction in murine B16 melanoma cells. Melanoma Research. 2(3). 197–206. 3 indexed citations

Winneker, Richard C., M M Wagner, & Baldev Singh. (1990). A novel, nonsteroidal inhibitor of androgen binding to the rat androgen binding protein: diethyl [[[3-(2,6-dimethyl-4-pyridinyl)-4-fluorophenyl]amino]methylene]propanedioate. Journal of Medicinal Chemistry. 33(1). 129–132. 5 indexed citations

Winneker, Richard C., et al.. (1989). Antiandrogens Do Not Reverse Androgen-Induced Inhibition of Sex Hormone-Binding Globulin Levels in Adult Female Rhesus Monkeys. Endocrinology. 125(2). 715–720. 11 indexed citations

10.

Winneker, Richard C., M M Wagner, & Frederick H. Batzold. (1989). Studies on the mechanism of action of win 49596: A steroidal androgen receptor antagonist. Journal of Steroid Biochemistry. 33(6). 1133–1138. 15 indexed citations

11.

Edwards, Richard, M M Wagner, & C B Moncrieff. (1984). Cell population and histochemistry of asbestos related lesions of rat pleural cavity after injection of various inorganic dusts.. Occupational and Environmental Medicine. 41(4). 506–513. 6 indexed citations

12.

Wagner, M M, Richard Edwards, C B Moncrieff, & J. C. Wagner. (1984). Mast cells and inhalation of asbestos in rats.. Thorax. 39(7). 539–544. 31 indexed citations

13.

Wagner, J. C., Ronald J. Hill, Geoffrey Berry, & M M Wagner. (1980). Treatments affecting the rate of asbestos-induced mesotheliomas. British Journal of Cancer. 41(6). 918–922. 5 indexed citations

14.

Campbell, Mark J., et al.. (1980). Sequential immunological studies in an asbestos-exposed population. II. Factors affecting lymphocyte function.. PubMed. 39(1). 176–82. 26 indexed citations

15.

Darke, C., et al.. (1979). HLA—A and B Antigen Frequencies in an Asbestos Exposed Population with Normal and Abnormal Chest Radiographs. Tissue Antigens. 13(3). 228–232. 17 indexed citations

16.

Wagner, M M. (1979). Thymectomy and asbestos-induced mesotheliomas in rats. British Journal of Cancer. 39(3). 337–341. 1 indexed citations

17.

Wagner, M M & C. Darke. (1979). HLA—A and B Antigen Frequencies in Welsh Coalworkers with Pneumoconiosis and Caplan's Syndrome. Tissue Antigens. 14(2). 165–168. 13 indexed citations

18.

Wagner, M M. (1976). Pathogenesis of Malignant Histiocytic Lymphoma Induced by Silica in a Colony of Specific-Pathogen-Free Wistar Rats. JNCI Journal of the National Cancer Institute. 57(3). 509–518. 14 indexed citations

19.

Embleton, M. J., R W Baldwin, J. C. Wagner, et al.. (1976). Assessment of cell‐mediated immunity to malignant mesothelioma by microcytotoxicity tests. International Journal of Cancer. 17(5). 597–601. 9 indexed citations

20.

Wagner, M M & J. C. Wagner. (1972). Lymphomas in the Wistar Rat After Intrapleural Inoculation of Silica. JNCI Journal of the National Cancer Institute. 49(1). 81–91. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact